217 related articles for article (PubMed ID: 35078243)
21. Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.
Bashash M; Shah A; Hislop G; Treml M; Bretherick K; Janoo-Gilani R; Leach S; Le N; Bajdik C; Brooks-Wilson A
PLoS One; 2013; 8(3):e59157. PubMed ID: 23527119
[TBL] [Abstract][Full Text] [Related]
22. Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
Yoon JY; Brezden-Masley C; Streutker CJ
BMC Cancer; 2020 Sep; 20(1):860. PubMed ID: 32894084
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy.
Pitter KL; Casey DL; Lu YC; Hannum M; Zhang Z; Song X; Pecorari I; McMillan B; Ma J; Samstein RM; Pei IX; Khan AJ; Braunstein LZ; Morris LGT; Barker CA; Rimner A; Alektiar KM; Romesser PB; Crane CH; Yahalom J; Zelefsky MJ; Scher HI; Bernstein JL; Mandelker DL; Weigelt B; Reis-Filho JS; Lee NY; Powell SN; Chan TA; Riaz N; Setton J
J Natl Cancer Inst; 2021 Mar; 113(3):266-273. PubMed ID: 32726432
[TBL] [Abstract][Full Text] [Related]
24. Somatic loss of ATM is a late event in pancreatic tumorigenesis.
Paranal RM; Jiang Z; Hutchings D; Kryklyva V; Gauthier C; Fujikura K; Nanda N; Huang B; Skaro M; Wolfgang CL; He J; Klimstra DS; Brand RE; Singhi AD; DeMarzo A; Zheng L; Goggins M; Brosens LA; Hruban RH; Klein AP; Lotan T; Wood LD; Roberts NJ
J Pathol; 2023 Aug; 260(4):455-464. PubMed ID: 37345735
[TBL] [Abstract][Full Text] [Related]
25. The enrichment of Fanconi anemia/homologous recombination pathway aberrations in ATM/ATR-mutated NSCLC was accompanied by unique molecular features and poor prognosis.
Wei W; Shi F; Xu Y; Jiao Y; Zhang Y; Ou Q; Wu X; Yang L; Lai J
J Transl Med; 2023 Dec; 21(1):874. PubMed ID: 38041093
[TBL] [Abstract][Full Text] [Related]
26. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY; Curran WJ; El-Rayes BF; Behera M; Patel PR
Cancer; 2020 Jan; 126(1):37-45. PubMed ID: 31532544
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma of the gastroesophageal junction in Chinese patients.
Huang Q
World J Gastroenterol; 2012 Dec; 18(48):7134-40. PubMed ID: 23326117
[TBL] [Abstract][Full Text] [Related]
28. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?
Dolan K; Morris AI; Gosney JR; Field JK; Sutton R
J Gastroenterol Hepatol; 2004 Jan; 19(1):24-30. PubMed ID: 14675239
[TBL] [Abstract][Full Text] [Related]
29. Adenocarcinoma of the GEJ: gastric or oesophageal cancer?
Rüschoff J
Recent Results Cancer Res; 2012; 196():107-13. PubMed ID: 23129369
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.
Yuasa N; Miyake H; Yamada T; Ebata T; Nimura Y; Hattori T
World J Surg; 2006 Mar; 30(3):364-71. PubMed ID: 16485063
[TBL] [Abstract][Full Text] [Related]
31. Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels.
van Dekken H; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Wink JC; van Duin M
Genes Chromosomes Cancer; 2008 Aug; 47(8):649-56. PubMed ID: 18438866
[TBL] [Abstract][Full Text] [Related]
32. Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme.
Soni M; Kiff C; Carroll R; Stein D; Saragoussi D; Nassar A; Maisey N; Tyas D
Future Oncol; 2021 Aug; 17(24):3163-3174. PubMed ID: 34098737
[TBL] [Abstract][Full Text] [Related]
33. Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Alvarez-Manceñido F; Jimenez-Fonseca P; Carmona-Bayonas A; Arrazubi V; Hernandez R; Cano JM; Custodio A; Pericay Pijaume C; Aguado G; Martínez Lago N; Sánchez Cánovas M; Cacho Lavin D; Visa L; Martinez-Torron A; Arias-Martinez A; López F; Limón ML; Vidal Tocino R; Fernández Montes A; Alsina M; Pimentel P; Reguera P; Martín Carnicero A; Ramchandani A; Granja M; Azkarate A; Martín Richard M; Serra O; Hernández Pérez C; Hurtado A; Gil-Negrete A; Sauri T; Morales Del Burgo P; Gallego J
Gastric Cancer; 2021 Jul; 24(4):926-936. PubMed ID: 33651195
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
Dominguez C; Rosa M; George TB; Pimiento J; Lauwers GY; Coppola D
Anticancer Res; 2018 Jan; 38(1):367-372. PubMed ID: 29277796
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
[TBL] [Abstract][Full Text] [Related]
38. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction.
van de Ven C; De Leyn P; Coosemans W; Van Raemdonck D; Lerut T
Eur J Cardiothorac Surg; 1999 Jun; 15(6):769-73. PubMed ID: 10431857
[TBL] [Abstract][Full Text] [Related]
39. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
[TBL] [Abstract][Full Text] [Related]
40. Unanswered questions in the management of gastroesophageal junction adenocarcinoma: an overview from the medical oncologist's perspective.
Shah MA
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
